Hassoun-Kheir, Nasreen
Buetti, Niccolò
Jaques, David
Olivier, Valérie
Chraiti, Marie-Noelle
Perez, Monique
de Kraker, Marlieke EA
Jackson, Holly
Schrenzel, Jacques
Saudan, Patrick
Harbarth, Stephan
Funding for this research was provided by:
University of Geneva
Article History
Received: 31 March 2025
Accepted: 6 August 2025
First Online: 20 August 2025
Declarations
:
: NHK has received partial funding support from Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 101034420 (Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance [PrIMAVeRa]) with support from the European Union’s Horizon 2020 Research and Innovation Programme and EFPIA. All other authors declare no conflicts of interest.